Virus World
377.6K views | +199 today
Follow
Virus World
Virus World provides a daily blog of the latest news in the Virology field and the COVID-19 pandemic. News on new antiviral drugs, vaccines, diagnostic tests, viral outbreaks, novel viruses and milestone discoveries are curated by expert virologists. Highlighted news include trending and most cited scientific articles in these fields with links to the original publications. Stay up-to-date with the most exciting discoveries in the virus world and the last therapies for COVID-19 without spending hours browsing news and scientific publications. Additional comments by experts on the topics are available in Linkedin (https://www.linkedin.com/in/juanlama/detail/recent-activity/)
Curated by Juan Lama
Your new post is loading...
Scooped by Juan Lama
Scoop.it!

Effect of Air Pollution on the Human Immune System -  Nature Medicine

Effect of Air Pollution on the Human Immune System -  Nature Medicine | Virus World | Scoop.it

Inhaled particulates from environmental pollutants accumulate in macrophages in lung-associated lymph nodes over years, compromising immune surveillance via direct effects on immune cell function and lymphoid architecture. These findings reveal the importance of improved air quality to preserve immune health against current and emerging pathogens.

The question

The world population is aging, and the majority of healthcare costs, morbidity and mortality that are associated with diseases concern individuals in the sixth decade of life and older. Thus, we need to improve our understanding of the underlying mechanisms that exacerbate disease susceptibility in elderly individuals. As starkly observed in the SARS-COV-2 pandemic, elderly individuals have increased susceptibility to respiratory infections as well as other lung diseases, such as chronic obstructive pulmonary disease and cancer. This susceptibility is attributed to senescent changes in immune cells, which result in systemic inflammation and functional impairments in adaptive immunity. However, the immune system is localized in mucosal and lymphoid tissues throughout the body, and the effect of aging on local immune responses has not been well-studied. The lung has continuous exposure to the environment, and the effect of this exposure on the immune system over age is not known. In this study, we investigated the role of atmospheric particulate matter in lung-associated immunity over the human lifespan.

The discovery

In our studies of human tissue immunity that used samples that were obtained from deceased human organ donors, we consistently observed that lymph nodes (LNs) associated with the lungs were black in color, owing to the presence of black particulate matter, whereas gut-associated LNs were the expected beige color, with no particulates. Thus, we began to investigate the effect of particulates on immune cells and LN architecture in these different LN sites using quantitative imaging and cellular and functional assays. We found that atmospheric particulate matter accumulated with age specifically in lung-associated LNs but not in gut-associated LNs, and this accumulation increased remarkably after age 40 (Fig. 1). Because lymphatic vessels connect LNs and tissues, one might expect that black particulates would disperse across other types of tissue-draining LNs; however, the fact that particulates became entrapped in lung-associated LNs suggested local effects of particulate matter on lung immunity. We found that particulates were contained within a specific subset of macrophages that was located in the T cell zone of the LN and not within follicles. Importantly, particulate-containing macrophages exhibited reduced activation, impaired production of pro-inflammatory cytokines and significantly reduced phagocytic capacity, whereas macrophages in the same LN that did not contain particulates did not exhibit these functional alterations. Particulate accumulation in lung-associated LNs further led to age-associated alterations in LN structural integrity, owing to the disruption of B cell follicles and lymphatic drainage. These results show that inhaled particulates have direct and cumulative effects on innate and adaptive immune processes that take place in the lymphoid organs that carry out immune surveillance of the lungs and respiratory tract.

The interpretation

Our study shows that pollutants in our environment have a direct and detrimental effect on the human immune system, and specifically the immune organs that are associated with the respiratory tract. LNs filter impurities and coordinate the clearance of harmful antigens and pathogens, but over decades the LNs connected to the lungs become clogged with particulates, and as a result they are not able to carry out essential functions of host defense and immune surveillance. In addition, the effects of pollutants are cumulative and can in part account for the worse outcome of respiratory infections in elderly individuals compared with younger populations. Our study raises important questions concerning the mechanisms by which particulates are contained by specific macrophage subsets in the LNs. It is unknown whether these macrophages are resident in the LN or whether they are derived from lung macrophages that migrate to the associated LN. It will be interesting to assess whether targeting certain macrophage populations may facilitate the clearance of particulate matter. Moreover, we showed that particulates impair the phagocytic capacity that is mediated by scavenger receptors that are expressed by macrophages. However, the effects of particulates on other pathways for phagocytosis of pathogens and cellular debris remain to be established. In addition, it will be important to understand the full effect of inhaled particulates in the resident immune cell populations in the lung itself, which is an area of ongoing investigation.

 

Published in Nature Medicine (Dec. 1, 2022):

https://doi.org/10.1038/s41591-022-02073-x

No comment yet.
Scooped by Juan Lama
Scoop.it!

New Clues About Why a Universal Flu Vaccine Is So Elusive

New Clues About Why a Universal Flu Vaccine Is So Elusive | Virus World | Scoop.it

Every year, we're reminded to return to the pharmacy for a flu shot. Why can't we have a flu vaccine that offers long-term protection, like those for measles or polio? That's because the influenza virus continuously evolves, so the immune response we build up one year might not work the next year—or even on the version of the flu you catch the same year. As a result, the virus remains dangerous: last year, it caused more than 60,000 deaths in the United States alone. New findings, published in Cell, reveal why making a general-purpose vaccine that guards against all versions of the flu is so hard: Instead of improving its memory of the previous version of virus, the immune system develops its response to the new virus variant from scratch, mostly using immune cells that have no memory of the virus. "If we can figure out how to help the immune system to keep building on what it has already learned, we could develop better vaccines for highly evolving viruses like the flu, or HIV, or Hepatitis C," says Gabriel D. Victora, assistant professor at Rockefeller.

 

Blocked memory

Victora and his team explored the behavior of immune cells in mice after a first and second exposure to a flu vaccine. Specifically, they looked at B cells, white blood cells that release antibodies. Antibodies are proteins that respond to invaders such as viruses by attacking them or tagging them for attack by other cells. During an infection or immunization, B cells enter so-called germinal centers in the lymph nodes, where they mutate many times until they evolve to target the new invader. "A germinal center is like a boot camp," says Victora. "They go in very bad, they come out very good, releasing better antibodies that bind more tightly to their targets." Those very good B cells are the immune system's cellular memory and can release antibodies that latch on to one part of the virus. Ideally, these B cells would return to the germinal centers the next time the body is faced with a virus or vaccine, and evolve even more sophisticated antibodies to target the slightly different version of the virus even better, ultimately becoming able to produce the so-called broadly neutralizing antibodies that the virus can't escape from. And that's what researchers need in order to make a universal vaccine. 

 

"The idea is you would keep calling memory cells back into germinal centers by repeated vaccination," Victora says, "in order to make them evolve several times until they become the super B cells that you need to give you a universal flu vaccine or an HIV vaccine." But instead of seeing the B cells return, the researchers found something different. They genetically marked the mice's germinal centers with fluorescent colors during the first vaccination so they could track the behavior of their descendants during the second vaccination. To their surprise, more than 90 percent of the B cells that entered the germinal centers on the second vaccination were uncolored—a sign that they were newcomers. A genetic analysis also revealed these cells hadn't gone through the mutation process that germinal center B cells typically undergo, further suggesting they were present in that site for the first time. The boot camp veterans, however, were mostly absent. Out of the hundreds of types of B cells that entered the germinal centers on the first vaccination, only a few made it back the second time, despite many of them being able to bind to the virus. It appears that coming back a second time is reserved only for a chosen few B cells....

 

Published in Cell (December 19, 2019):

https://doi.org/10.1016/j.cell.2019.11.032

No comment yet.